Monarch earnings missed by $0.10, revenue fell short of estimates
Monarch (MCRI) reported Q3 EPS of $1.76, missing estimates by $0.10, with revenue at $146.26M, below the $148M consensus. The stock is down 6.09% over 3 months but up 25.10% year-over-year. InvestingPro rates its financial health as 'great performance'.
How this was made
The 30-second read
Why it matters
The earnings miss is the primary new information driving potential price movement.
Market read
Primary earnings disclosure for a US-listed small-cap; likely short-term price impact.
What to watch
Potential upcoming product pipeline announcements could offset the earnings disappointment.
Background
Monarch (NASDAQ: MCRI) is a small-cap company whose quarterly earnings were just released.
Ticker impact
Monarch reported Q3 EPS of $1.76, missing estimates by $0.10 and revenue of $146.26M fell short of the $148M consensus.
downward pressure as the market prices in the earnings miss
The miss on both EPS and revenue is a fresh primary disclosure that typically triggers a sell-off for small-cap earnings beats.
Market effects
May weigh on other small-cap biotech/healthcare stocks reporting similar results.
Limited to US small-cap segment.
Low global impact.
Counterpoint
If the miss is within expectations, the stock could rebound on a short-cover rally.
Key entities
- companyMonarch
Issuer of the earnings report.
